While the implications of Brexit on drug regulation in the UK are largely unknown, the government needs to consider its options quickly to avoid delaying public access to important medicine.
Rare but not forgotten: why drug appraisal methods must be updated to consider treatments for rare diseasesSubscription
The UK government needs to adapt its drug and technology appraisal methods to prevent patients with rare diseases being left out in the cold.
Restricting what is allowed on prescription in England: views from healthcare professionals and patient groupsSubscription
We ask healthcare professionals across primary care and patient groups for their thoughts on NHS England’s decision to review what GPs are allowed to prescribe.
Books and Arts
Introduction to drug disposition and pharmacokinetics, by Stephen H Curry and Robin Whelpton
Earache is a common problem that can be the result of a variety of different pathologies. It is important for pharmacists and healthcare professionals to appropriately diagnose primary and secondary earache and ear infections.
Advising patients on halitosis and oral hygieneSubscription
Halitosis (bad breath) is estimated to be the third most frequent reason for patients to seek dental care, following tooth decay and gum disease. Pharmacists are ideally placed to promote oral health and provide patients with advice on the prevention and management of halitosis.
What pharmacist Sini Eskola does at the European Federation of Pharmaceutical Industries and Associations (EFPIA)Subscription
Forming a view on complicated matters, involving legislation and policy, which influence many parts of pharmaceutical industry businesses, is an important challenge, says Sini Eskola.
From pharmacy technician to pharmacistSubscription
There is no easy career path for pharmacy technicians who want to become pharmacists. Steve Hemsley finds out more about the process and how some technicians have made it work.
As a multi-site pharmacy manager for LloydsPharmacy and lead pharmacist based in the Carleton Clinic, a mental health hospital in Carlisle, John Mowat talks about his career and role in providing the medication supply service for Cumbria Partnership Foundation Trust.
High Court throws out legal challenge over GPhC standards but PDA says ruling provides “welcome clarification”
The Pharmacists’ Defence Association (PDA) has lost its High Court challenge over changes to professional standards for pharmacists which it claimed threatened a pharmacist’s human rights.
‘Next steps on the NHS five year forward view’ outlines progress made so far and highlights priorities for the next few years, including plans for 900 clinical pharmacists in GP surgeries by 2018 and over 1,300 by 2019.
NHS England has identified a number of medicines that should no longer be available on prescription in a move that would save the NHS £128m a year.
Sildenafil — the prescription-only medicine branded as Viagra for the treatment of erectile dysfunction — could become a pharmacy (P) medicine if government proposals go ahead.
Researchers have identified the drug classes that are frequently implicated in causing acute kidney injury after analysing adverse drug reactions in a French national pharmacovigilance database.
A study of 3,660 patients across eight countries has identified the types of inhaler technique errors that are associated with the greatest impact on asthma outcomes.
News in Brief
The total value of the community pharmacy contract in Wales will remain at £144.3m for the 2017–2018 financial year, health secretary Vaughan Gething has reaffirmed.
Boots is extending its private human papillomavirus (HPV) vaccination service to make it available to boys and men aged 12–44 years.
The US Food and Drug Administration (FDA), which is responsible for evaluating the safety and efficacy of medicines in the United States, has given the green light to valbenazine (Ingrezza), the first drug to be approved for treating adults with tardive dyskinesia.
The pharmacy regulator is pushing ahead with its controversial proposal to amend professional standards which means pharmacists cannot put their own religious or other beliefs ahead of providing patient-centred care.
The Faculty of Sexual and Reproductive Healthcare (FSRH) has urged pharmacists and doctors to explain to patients that the emergency contraceptive pill can be ineffective in women weighing 11 stone or more, or with a body-mass index of 26 or above.
The option to have pharmacy registration assessments re-marked will be removed from 2017, the General Pharmaceutical Council (GPhC) has announced.
The US Food and Drug Administration (FDA), which is responsible for evaluating the safety and efficacy of medicines in the United States, has approved the use of ocrelizumab (Ocrevus; Genentech) for adult patients with relapsing forms of multiple sclerosis (MS) and primary progressive multiple sclerosis (PPMS).
The US Food and Drug Administration (FDA), which is responsible for evaluating the safety and efficacy of medicines in the United States, has approved the use of dupilumab (Dupixent; Regeneron Pharmaceuticals) to treat adults with atopic dermatitis.
A list of generic drugs — including 41 that are available in the UK — have been recommended for suspension across the EU because of doubts over the quality of the bioequivalence data used to grant their national marketing authorisation.
Preparing our future pharmacistsSubscription
Helping to develop our professionSubscription
Sunscreen should not be seen as a beauty productSubscription
Be careful how you promote the NMS to patientsSubscription